Profile cover photo
Profile photo
MAPS
5,580 followers -
Supporting psychedelic and medical marijuana research since 1986
Supporting psychedelic and medical marijuana research since 1986

5,580 followers
About
MAPS's posts

Post has attachment
Public
Second and Third Participants Self-Administered Treatment in Trial of Marijuana for Chronic PTSD in Veterans

On February 9 and February 22, 2017, the second and third participants in the first-ever clinical trial of smoked marijuana (cannabis) for posttraumatic stress disorder (PTSD) in U.S. veterans self-administered treatment at the Scottsdale Research Institute (SRI) in Phoenix, Ariz. bit.ly/2n3Dh5T

Photo

Post has attachment
Public
Scientists Have Completed Trials Attempting to Cure Tinnitus with MDMA

A new scientific study explores the use of MDMA as a treatment for tinnitus, a condition characterized by uncontrollable ringing in the ears. bit.ly/2nQFdU4

Photo

Post has attachment
Public
This weekend in Portland, the annual +Students for Sensible Drug Policy (SSDP) conference will explore the role of psychedelics in science and policy. Allison Wilens of MAPS Public Benefit Corporation - MPBC will speak about psychedelic research during the Mechanisms of Psychedelic Psychotherapy panel discussion, and Natalie Lyla Ginsberg and Ismail Ali of MAPS will be featured in the Psychedelic Law & Policy: Past, Present, and Future panel discussion. ssdp.org/events/ssdp2017
Photo

Post has attachment
Public
The therapeutic potential of microdosing LSD is discussed by Dr. Drew Pinsky, author Ayelet Waldman, and Dr. Bruce Heischober on a new Weekly Infusion podcast.

Post has attachment
Public
Psychedelic Science 2017 Partner: +Psymposia
 
Psymposia is an organization focusing on how the big emerging social issues of psychedelic science, drug reform, and harm reduction affect society, law, and medicine. psymposia.com
Photo

Post has attachment
Public
Comedian Shane Mauss speaks about the relationship between comedy and psychedelics. “Comedy is about looking at life in a different way,” says Mauss. “Psychedelics just force a different perception on you.” Mauss’ comedy will be featured during the Psychedelic Comedy Banquet at Psychedelic Science 2017. http://bit.ly/2mVlBtz
Photo

Post has attachment
Public
The March 2017 edition of +Rolling Stone features two new investigative reports on psychedelic research, “The Psychedelic Miracle” (rol.st/2mayYWA) and “What Psychedelics Really Do to Your Brain” (rol.st/2ntkanc).

Photo

Post has attachment
Public
Psychedelics Today interviews Natalie Lyla Ginsberg of MAPS about the current state of global drug policy. “Through my lens, so many problems in this world are driven by people acting from a reactionary place of fear and pain instead of from a place of compassion or love,” explains Ginsberg.

Post has attachment
Public
Psychedelic Science 2017 Partner: Nucleus of Research on Psychoactive Substances (NEIP)
 
NEIP brings together scholars to promote a joint reflection on human sciences. The NEIP website is a space for useful academic dialogue among people who feel compelled to take a political and ethical stance on the issue of drugs. neip.info
Photo

Post has attachment
Public
MDMA-Assisted Psychotherapy for Anxiety Associated with Life-Threatening Illness in Marin

On February 26, 2017, the 18th and final participant enrolled in our ongoing study of MDMA-assisted psychotherapy for anxiety associated with life-threatening illness. On February 13, 2017, the 17th of 18 participants was treated. bit.ly/2nabmEA
Photo
Wait while more posts are being loaded